This study is for adults with chronic myeloid leukemia (CML) who previously tried to stop their daily medication but saw their cancer return. It tests whether restarting a specific drug called nilotinib for at least two years can help patients successfully stop treatment a second…
Phase: PHASE2 • Sponsor: European LeukemiaNet • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC